Antiplatelet and antithrombotic activities of CP201, a newly synthesized 1,4-naphthoquinone derivative

College of Pharmacy, Chungbuk National University, Cheongju 361-763, South Korea.
Vascular Pharmacology (Impact Factor: 3.64). 03/2004; 41(1):35-41. DOI: 10.1016/j.vph.2004.04.001
Source: PubMed


The antiplatelet and antithrombotic activities of a newly synthesized CP201, 2-(3,5-di-tert-butyl-4-hydroxyl)-3-chloro-1,4-naphthoquinone on human platelet aggregation in vitro and murine pulmonary thrombosis in vivo were examined. In addition, the antiplatelet activity of CP201 involved in calcium-signaling cascade was also investigated. CP201 showed concentration-dependent inhibitory effects on platelet aggregation induced by collagen and thrombin, with IC50 values of 4.1+/-0.3 and 4.6+/-0.4 microM, respectively. Orally administered CP201 protected mice against the collagen plus epinephrine-induced thromboembolic death in a dose-dependent manner. On the other hand, CP201 did not alter such coagulation parameters as activated partial thromboplastin time (APTT), prothrombin time (PT), and thrombin time (TT) in human plasma in vitro. These results suggest that the antithrombotic activity of CP201 may be due to antiplatelet rather than anticoagulation activity. CP201 potently inhibited platelet aggregation challenged by calcium ionophore A23187 and thapsigargin, which is a selective inhibitor of the Ca(2+)-ATPase pump, in a concentration-dependent manner, indicating that CP201 may have an inhibitory effect on calcium-signaling cascade. This was supported by measuring [Ca2+]i in platelets loaded with fura-3AM, where CP201 inhibited the rise in cytosolic Ca2+ mediated by thrombin. Taken together, these results suggest that CP201 may be a promising antithrombotic agent, and the antithrombotic effect of CP201 may be due to antiplatelet activity, which was mediated, at least partly, by the inhibition of cytosolic calcium mobilization.

Download full-text


Available from: Dong Ju Son, Oct 01, 2014
  • Source
    • "Also, exogenous synthetic quinones (or quinones isolated from natural sources) have been shown to inhibit different physio-pharmacological targets, to cause oxidative stress and cell death of microbes [7]. Furthermore, different naphthoquinones have been reported and clinically used as anticancer, antifungal, antiprotozoal, and antibacterial therapeutic agents, as well as platelet antiaggregants and to prevent the myotoxicity of snake venom [8] [9] [10] [11] [12] [13] [14]. Their biological activity has been ascribed to their electronic properties and, in some cases, to specific interactions with defined targets such as DNA and dihydroorotate dehydrogenase [15]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: This work deals with the synthesis and evaluation of new compounds designed by combination of 1,4-naphthoquinone and ferrocene fragments in a 3-ferrocenylmethyl-2-hydroxy-1,4-naphthoquinone arrangement. A practical coupling reaction between 2-hydroxy-1,4-naphthoquinone and ferrocenemethanol derivatives has been developed. This procedure can be carried out "on-water", at moderate temperatures and without auxiliaries or catalysts, with moderate to high yields. The synthesized derivatives have shown significant in vitro antiplasmodial activity against chloroquine-sensitive and resistant Plasmodium falciparum strains and it has been shown that this activity is not related to the inhibition of biomineralization of ferriprotoporphyrin IX. Binding energy calculations and docking of these compounds to cytochrome b in comparison with atovaquone have been performed.
    Full-text · Article · Oct 2013 · European Journal of Medicinal Chemistry
  • Source
    • "Platelets are blood cells that participate in the human primary hemostatic mechanism. Platelet-platelet interaction has the final purpose to produce a platelet thrombus that constitutes the primary hemostatic plug [24]. In addition, platelet adhesion and aggregation on blood vessel walls contribute to the occurrence of thrombosis and emboli formation, and have relation with other cardiovascular diseases [25–27]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: In a previous work based on popular belief, Campomanesia xanthocarpa Berg., popularly known as "guavirova", showed to have a potential effect in the control of a number of conditions associated with cardiovascular diseases. The aim of the present work was to investigate the effects of C. xanthocarpa extract (CXE) on antiplatelet, antithrombotic and fibrinolytic activities in mice and in human blood. Mice were treated orally for 5 days with CXE or acetylsalicylic acid and at the end of the treatment period animals were challenged for bleeding, acute thromboembolism and ulcerogenic activity. In addition, we have assessed the prothrombin time and activated partial thromboplastin time (aPTT) after oral administration. In in vitro assays, antiplatelet effects of CXE was evaluated on platelet aggregation, and fibrinolytic activity of the extract was observed by mice or human artificial blood clot degradation. Platelet citotoxicity of the extract was also determined by the LDH assay. Results demonstrated that CXE has a significant protective effect on thrombosis. It also inhibits platelet aggregation without demonstrating cytotoxicity on platelets. CXE slightly prolonged aPTT and showed no ulcerogenic activity after oral administration. In addition, CXE showed a fibrinolytic activity. Thus, C. xanthocarpa showed antiplatelet, antithrombotic and fibrinolytic activities in mice.
    Full-text · Article · Jan 2012 · Evidence-based Complementary and Alternative Medicine
  • [Show abstract] [Hide abstract]
    ABSTRACT: The CCITT Common Channel Signalling System# 7 is a packet-switched network used to carry call signalling and control messages independently of the underlying telecommunications network. This paper derives the mean and worst-case packet delay experienced in a 6 node network under conditions involving multiple node failures using BCMP analysis. The result is generalized to be applicable to both symmetric and asymmetric traffic loads. Numerical results are based on actual performance measurements on the Singapore National network
    No preview · Conference Paper · Dec 1992
Show more